Department of Neurology, Peking University Third Hospital, Beijing, China; Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative diseases, Beijing, China.
Department of Neurology, Peking University Third Hospital, Beijing, China; Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative diseases, Beijing, China; Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China.
Neurobiol Aging. 2021 Jan;97:149.e9-149.e15. doi: 10.1016/j.neurobiolaging.2020.07.028. Epub 2020 Aug 4.
TBK1 has been reported as a risk gene of amyotrophic lateral sclerosis (ALS). We screened TBK1 variants in 69 familial ALS patients and 608 sporadic ALS patients from mainland China. All 20 coding exons and the exon-intron flanking regions of TBK1 were amplified and sequenced using Sanger sequencing. In total, we identified eight missense variants and one suspicious splice site mutation. The patient with K291R had a family history of ALS. Other variants were detected in sALS patients. Interestingly, 2 patients with variants in TBK1 carried another variant in other genes related to autophagy: G175S in TBK1 and P392L in SQSTM1; and D534H in TBK1 and E372D in SQSTM1. We concluded that TBK1 variants account for approximately 1.3% of Chinese ALS patients. Screening for this gene in ALS patients is necessary, especially in the group with variants in other genes related to the autophagy pathway.
TBK1 已被报道为肌萎缩侧索硬化症(ALS)的风险基因。我们在中国大陆的 69 名家族性 ALS 患者和 608 名散发性 ALS 患者中筛选了 TBK1 变体。使用 Sanger 测序对 TBK1 的所有 20 个编码外显子和外显子-内含子侧翼区进行扩增和测序。总共鉴定出 8 个错义变体和 1 个可疑剪接位点突变。携带 K291R 的患者有 ALS 的家族史。其他变体在 sALS 患者中被检测到。有趣的是,2 名携带 TBK1 变异的患者在其他与自噬相关的基因中携带另一种变异:TBK1 中的 G175S 和 SQSTM1 中的 P392L;以及 TBK1 中的 D534H 和 SQSTM1 中的 E372D。我们得出结论,TBK1 变体约占中国 ALS 患者的 1.3%。在 ALS 患者中筛查该基因是必要的,尤其是在与自噬途径相关的其他基因有变异的患者中。